Variability in breast cancer care across institutions can be significant, particularly in pathology and radiology review and the use of early-stage treatments.

“I I don't think there's one specific area that jumps out I think that where things can get um you know I think the value added of um you know some of the cancer centers that we've been discussing uh really thoughtful review of the pathology and Radiology uh these are things that are not often visible to patients um but the experience of the Radiology team working with the surgeons you know are they really satisfied that that little ditel doesn't need to be biopsied um is the pathology First Rate did they really make sure that um the grade was called correctly that the estrogen receptor was studies were correct done those are incredibly important things and um While most places do it very well those are things that can can really alter longer term outcomes another area is um judicious use of treatment so um there are a lot of drugs that we can use in uh early stage breast cancer and dialing in the right amount is a bit of an art form”